Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: -

S-e-banken Legemiddel

+ Add to Watchlist

SELEGEM:NO

55.14 NOK 0.42 0.76%

As of 02:59:30 ET on 02/27/2015.

Snapshot for S-e-banken Legemiddel (SELEGEM)

Year To Date: +7.34% 3-Month: +15.87% 3-Year: +36.76% 52-Week Range: 34.25 - 54.83
1-Month: +1.08% 1-Year: +50.16% 5-Year: +23.08% Beta vs OBX: 0.50

Mutual Fund Chart for SELEGEM

No chart data available.
  • SELEGEM:NO 55.14
  • 1M
  • 1Y
Interactive SELEGEM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for SELEGEM

SEB Legemiddel Fund is an open-end fund incorporated in Sweden. The Fund invests primarily in equities and equity related securities of major pharmaceutical, medical technology, biotechnology and medical services companies.

Inception Date: 09-15-1999 Telephone: 47-810-01-050
Managers: -
Web Site: www.seb.no/fonder

Fundamentals for SELEGEM

NAV (on 2015-02-27) 55.14
Assets (M) (on 2010-05-28) 382.75
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for SELEGEM

No dividends reported

Fees & Expenses for SELEGEM

Front Load -
Back Load -
Current Mgmt Fee -
Redemption Fee -
12b1 Fee -
Expense Ratio -

Top Fund Holdings for SELEGEM

Filing Date: 09/30/2013
Name Position Value % of Total
Roche Holding AG 302 490,802 8.800%
AbbVie Inc 1,450 390,410 7.000%
Johnson & Johnson 588 306,751 5.500%
AstraZeneca PLC 855 267,710 4.800%
Eli Lilly & Co 810 245,401 4.400%
Abbott Laboratories 1,201 239,823 4.300%
Medtronic PLC 748 239,823 4.300%
Amgen Inc 314 211,937 3.800%
Aetna Inc 535 206,360 3.700%
HCA Holdings Inc 780 200,782 3.600%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil